Peptides Similar to MVT-602

Peptides Related to MVT-602#

MVT-602 belongs to the kisspeptin family of reproductive peptides. Its primary clinical niche is as an IVF oocyte maturation trigger, placing it in comparison with other triggering agents used in assisted reproduction.

Kisspeptin-54 (Native Kisspeptin)#

Kisspeptin-54 is the endogenous 54-amino acid peptide that activates KISS1R on hypothalamic GnRH neurons. Professor Waljit Dhillo's group at Imperial College London has pioneered its use as an IVF trigger, demonstrating zero OHSS cases in triggered cycles.

MVT-602 was designed to improve on kisspeptin-54's limitations: a short half-life (28 minutes), brief LH surge (4.7 hours), and the need for a large 54-amino acid peptide that is expensive to manufacture.

hCG (Human Chorionic Gonadotropin)#

hCG is the current standard IVF trigger. It directly activates LH receptors on granulosa cells, triggering final oocyte maturation. However, its long half-life (24-36 hours) sustains ovarian stimulation after the trigger, which is the primary driver of OHSS.

MVT-602's advantage is its self-limiting mechanism: the LH surge is generated through the endogenous kisspeptin-GnRH-LH pathway and is regulated by natural feedback mechanisms, preventing the sustained ovarian hyperstimulation that causes OHSS.

GnRH Agonists (Leuprolide as Trigger)#

GnRH agonists are used as alternative triggers in high-risk OHSS patients. They cause a pituitary LH/FSH flare that can trigger oocyte maturation. While OHSS rates are very low, the resulting LH surge is often brief and may not adequately support corpus luteum function, leading to lower pregnancy rates without aggressive luteal support.

MVT-602's prolonged LH surge (21-22 hours) may offer a middle ground: OHSS safety comparable to GnRH agonist triggers with a more robust LH surge approaching that of hCG.

Summary Comparison#

Comparison Context#

MVT-602 belongs to the Reproductive category of research peptides. Comparing MVT-602 with related compounds helps researchers understand its relative positioning in the therapeutic landscape. Each compound has distinct advantages and limitations that should be considered based on the specific research question or clinical need.

Detailed Comparisons#

The following peptides and compounds are most closely related to MVT-602 in mechanism, indication, or therapeutic category:

MVT-602 vs Kisspeptin-54#

Similarity: Very high - MVT-602 is a synthetic analog of kisspeptin designed with enhanced metabolic stability and prolonged duration of action

Key Differences: Kisspeptin-54 is the native 54-amino acid peptide with a 28-minute half-life and 4.7-hour LH peak. MVT-602 is a 9-amino acid modified analog with 108-minute half-life and 21-22-hour LH peak.

Advantages of Kisspeptin-54: 4-fold longer half-life, 4-fold greater LH AUC, more closely mimics natural mid-cycle LH surge, simpler to manufacture (9 vs 54 amino acids)

Disadvantages of Kisspeptin-54: Less clinical data than kisspeptin-54 in IVF settings, synthetic modifications may carry unknown risks, investigational status

Researchers choosing between MVT-602 and Kisspeptin-54 should consider the development stage, available evidence, and specific research objectives when making their selection.

MVT-602 vs Gonadorelin (GnRH)#

Similarity: Moderate - Both trigger LH release through the hypothalamic-pituitary axis, but at different levels of the cascade

Key Differences: Gonadorelin directly stimulates GnRH receptors on pituitary gonadotrophs. MVT-602 acts upstream by activating KISS1R on GnRH neurons, triggering endogenous GnRH release for a more physiological LH surge.

Advantages of Gonadorelin (GnRH): More physiological LH surge profile, prolonged duration, works through the natural kisspeptin-GnRH-LH cascade

Disadvantages of Gonadorelin (GnRH): Investigational only, more complex mechanism requiring intact hypothalamic kisspeptin-GnRH neuronal circuit

Researchers choosing between MVT-602 and Gonadorelin (GnRH) should consider the development stage, available evidence, and specific research objectives when making their selection.

MVT-602 vs Human Chorionic Gonadotropin (hCG)#

Similarity: Moderate - Both are used as oocyte maturation triggers in IVF, but through fundamentally different mechanisms

Key Differences: hCG directly activates LH receptors with a long half-life (24-36 hours), while MVT-602 triggers a self-limiting endogenous LH surge through the kisspeptin-GnRH pathway.

Advantages of Human Chorionic Gonadotropin (hCG): Expected lower OHSS risk, physiological LH surge profile, self-limiting mechanism with natural feedback regulation

Disadvantages of Human Chorionic Gonadotropin (hCG): Investigational status, no proven pregnancy outcomes data, may produce insufficient LH in some patients, requires intact HPG axis

Researchers choosing between MVT-602 and Human Chorionic Gonadotropin (hCG) should consider the development stage, available evidence, and specific research objectives when making their selection.

Related Reading#

• MVT-602 overview and research guide
• MVT-602 research evidence
• MVT-602 dosing protocols